DE69130457T2 - Peptidfragmente des env-proteins vom immunschwäche-virus der katze und ihre verwendung in der diagnostik - Google Patents

Peptidfragmente des env-proteins vom immunschwäche-virus der katze und ihre verwendung in der diagnostik

Info

Publication number
DE69130457T2
DE69130457T2 DE69130457T DE69130457T DE69130457T2 DE 69130457 T2 DE69130457 T2 DE 69130457T2 DE 69130457 T DE69130457 T DE 69130457T DE 69130457 T DE69130457 T DE 69130457T DE 69130457 T2 DE69130457 T2 DE 69130457T2
Authority
DE
Germany
Prior art keywords
antibodies
peptide
vif
glu
peptide fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69130457T
Other languages
German (de)
English (en)
Other versions
DE69130457D1 (de
Inventor
Alexandre F-94400 Vitry-Sur-Seine Avrameas
Jean Gerard F-94450 Limeil-Brevannes Guillet
Anne F-94210 La Varenne-Saint-Hilaire Moraillon
Arthur Donny F-75015 Paris Strosberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Application granted granted Critical
Publication of DE69130457D1 publication Critical patent/DE69130457D1/de
Publication of DE69130457T2 publication Critical patent/DE69130457T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K16/114—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69130457T 1990-11-21 1991-11-20 Peptidfragmente des env-proteins vom immunschwäche-virus der katze und ihre verwendung in der diagnostik Expired - Lifetime DE69130457T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9014519A FR2669338A1 (fr) 1990-11-21 1990-11-21 Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.
PCT/FR1991/000917 WO1992009632A1 (fr) 1990-11-21 1991-11-20 Fragments de la proteine env du virus de l'immunodeficience feline, anticorps et leurs applications dans le diagnostic

Publications (2)

Publication Number Publication Date
DE69130457D1 DE69130457D1 (de) 1998-12-10
DE69130457T2 true DE69130457T2 (de) 1999-05-27

Family

ID=9402430

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69130457T Expired - Lifetime DE69130457T2 (de) 1990-11-21 1991-11-20 Peptidfragmente des env-proteins vom immunschwäche-virus der katze und ihre verwendung in der diagnostik

Country Status (5)

Country Link
EP (1) EP0564477B1 (Direct)
AT (1) ATE172983T1 (Direct)
DE (1) DE69130457T2 (Direct)
FR (1) FR2669338A1 (Direct)
WO (1) WO1992009632A1 (Direct)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591572A (en) * 1991-06-14 1997-01-07 St. Vincents Institute Of Medical Research Limited Detection of mammalian immunodeficiency viruses
FR2692270A1 (fr) * 1992-06-16 1993-12-17 Centre Nat Rech Scient Peptides immunogènes et/ou neutralisants de vif de souche WO et leurs applications au diagnostic et à la prévention de l'immunodéficience féline.
ATE278018T1 (de) * 1992-06-16 2004-10-15 Centre Nat Rech Scient Nukleotid- und peptidsequenzen des immunschwächevirus der katze, isolat wo und anwendungen der sequenzen in der diagnostik und zur verhinderung der infektion
FR2692269B1 (fr) * 1992-06-16 1995-05-19 Centre Nat Rech Scient Peptides immunogènes et/ou neutralisants de vif de souche WO et leurs applications au diagnostic et à la prévention de l'immunodéficience féline.
FR2692279B1 (fr) * 1992-06-16 1995-05-19 Centre Nat Rech Scient Séquences nucléotidiques issues de la souche WO du vif et leurs fragments, applications desdites séquences à l'expression de peptides immunogènes et au diagnostic de l'immunodéficience féline.
GB9215232D0 (en) * 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
GB9215233D0 (en) * 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
GB9219936D0 (en) * 1992-09-21 1992-11-04 Pitman Moore Inc Vaccines
EP0670901A1 (en) * 1993-03-11 1995-09-13 Akzo Nobel N.V. Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus
US6300118B1 (en) 1995-06-07 2001-10-09 American Home Products Corporation Plasmids comprising a genetically altered feline immunodeficiency virus genome
US5849303A (en) * 1995-06-07 1998-12-15 American Home Products Corporation Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
FR2769916B1 (fr) * 1997-10-17 2000-12-01 Centre Nat Rech Scient Peptides issus du gene env du virus de l'immunodeficience feline et leurs applications immunoprotectrices et vaccinales
WO2005026733A1 (en) 2003-09-11 2005-03-24 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
AU2005267607B8 (en) 2003-09-11 2009-07-16 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
EP1709447B1 (en) * 2003-12-18 2009-06-24 Idexx Laboratories, Inc. Method for detecting feline immunodeficiency virus
AU2005215629B2 (en) * 2004-02-19 2009-01-29 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
EP1761556A1 (en) 2004-06-30 2007-03-14 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus (fiv) comprising the use of peptides derived from the v3 region of the fiv env protein
US7291338B2 (en) 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
EP2553452B1 (en) 2010-04-02 2015-03-04 IDEXX Laboratories, Inc. Detection of feline immunodeficiency virus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219725A (en) * 1988-12-05 1993-06-15 Idexx Laboratories Incorporated Monoclonal antibodies to feline-t-lymphotropic lentivirus
EP0471752A4 (en) * 1989-05-08 1992-09-02 Idexx Corp. Polypeptides of feline t-cell lymphotropic lentivirus

Also Published As

Publication number Publication date
WO1992009632A1 (fr) 1992-06-11
EP0564477B1 (fr) 1998-11-04
EP0564477A1 (fr) 1993-10-13
FR2669338B1 (Direct) 1995-03-03
ATE172983T1 (de) 1998-11-15
FR2669338A1 (fr) 1992-05-22
DE69130457D1 (de) 1998-12-10

Similar Documents

Publication Publication Date Title
DE69130457T2 (de) Peptidfragmente des env-proteins vom immunschwäche-virus der katze und ihre verwendung in der diagnostik
DE3853422T2 (de) HIV-3-Retrovirus und seine Verwendung.
DE3588251T2 (de) DNS-Fragmente des GAG-Gens von LAV
DE68929467T2 (de) HIV-2 Varianten
EP0673948B1 (de) Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
EP0591914B1 (de) Retrovirus aus der HIV-Gruppe und dessen Verwendung
DE3587969T2 (de) Testverfahren zum nachweis von menschlichem lymphotropischem virus.
DE3751310T2 (de) Peptide zur Diagnose von HTLV-III-Antikörpern, deren Herstellung und Verwendung.
DE3876496T2 (de) Synthetisches peptid-antigen fuer nachweis von hiv-2-infektionen.
DE3783282T2 (de) Varianten von lav-viren, deren dns- und proteinkomponenten und deren verwendung, insbesondere zu diagnostischen zwecken und zur herstellung von immunogenen zusammensetzungen.
DE69535601T3 (de) Nukleotiden-sequenzen aus retroviren-antigenen hiv-i gruppe (oder untergruppe) o
DE68916421T2 (de) Synthetische peptidantigene zum nachweis von htlv-1-infektionen.
DE69130396T2 (de) Vergrössertes western blot format und ein immunotestverfahren für die bestimmung von viralen antikörpern
DD284046A5 (de) Verfahren zur herstellung eines aids-diagnostikums
DE69223250T2 (de) Detektion des immunschwäche-virus aus felis
EP0972198B2 (de) Verfahren zur simultanen bestimmung von hiv-antigenen und hiv-antikörpern
DE3490048T1 (de) Synthetische Polypeptide aus viralen Oncogenen
DE60015312T2 (de) Anti-hiv-1 impfstoff enthaltend das ganzen hiv-1 tat protein oder ein teil davon
DE69327529T2 (de) Immunologisch mit HLA homologe HIV Protein Epitope
EP0922958A2 (de) Entstörung von diagnostischen Verfahren durch Peptide aus D-Aminosäuren
DE3889581T2 (de) Monoklonale Antikörper gegen spezifische antigene Regionen des humanen Immundefizienzvirus und Methoden zur Verwendung.
DE69333636T2 (de) Nukleotid- und Peptidsequenzen des Immunschwächevirus der Katze, Isolat WO und Anwendungen der Sequenzen in der Diagnostik und zur Verhinderung der Infektion
DE69028561T2 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
DE69009066T2 (de) SIV cpz-ant Retrovirus und seine Anwendungen.
EP0305777A2 (de) Herstellung von Antigenen des Human Immunodeficiency Virus Typ 1 sowie deren Verwendung als diagnostisches Mittel und Therapeutikum

Legal Events

Date Code Title Description
8364 No opposition during term of opposition